Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT05993611 · SUSPENDED

Trial details

NCT number

NCT05993611

Sponsor

City of Hope Medical Center

Status

SUSPENDED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2024-02-19

Primary completion

2028-05-21

Enrollment

27

View on ClinicalTrials.gov